PREVENTION OF MALIGNANT EXOPHTHALMOS AFTER TREATMENT OF THYROTOXICOSIS
- 26 May 1973
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 301 (7813) , 1196
- https://doi.org/10.1016/s0140-6736(73)91210-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Demonstration of Delayed Hypersensitivity to Retrobulbar and Thyroid Tissues in Human ExophthalmosJournal of Clinical Endocrinology & Metabolism, 1972
- Immunosuppressive Therapy for the Eye Changes of Graves' DiseaseJournal of Clinical Endocrinology & Metabolism, 1970
- Behavior “recovery” during chronic reserpine treatment: Effect of dose of reserpinePsychopharmacology, 1969
- Effects of imipramine and reserpine in depressionPsychopharmacology, 1969
- CONTROLLED TRIAL OF PROPRANOLOL IN THYROTOXICOSISThe Lancet, 1969
- Drug responses in hyperthyroid children suggesting an endogenous false transmitterClinical Pharmacology & Therapeutics, 1968
- The action of reserpine in imipramine-resistant depressive patientsPsychopharmacology, 1967
- PREDNISONE IN EMERGENCY TREATMENT OF MALIGNANT EXOPHTHALMOSThe Lancet, 1966
- EFFECT OF ADRENERGIC RECEPTOR BLOCKADE ON THE TACHYCARDIA OF THYROTOXICOSIS AND ANXIETY STATEThe Lancet, 1965
- Combined administration of desipramine and reserpine or tetrabenazine in depressive patientsPsychopharmacology, 1963